Publications by authors named "A Carazo"

Familial hypercholesterolemia (FH) is a relatively rare genetic disease associated with high serum cholesterol levels but also with abnormalities in blood coagulation. Novel pharmacotherapeutic approaches in FH including proprotein convertase subtilisin/kexin type 9 antibodies (PCSK9Ab) are very efficient in decreasing cholesterol levels but their impact on coagulation in FH is not yet established. Therefore, we hypothesized that these novel antidyslipidemic drugs can positively impact blood coagulation due to their more potent effect on cholesterol.

View Article and Find Full Text PDF

The human body is regularly exposed to simple catechols and small phenols originating from our diet or as a consequence of exposure to various industrial products. Several biological properties have been associated with these compounds such as antioxidant, anti-inflammatory, or antiplatelet activity. Less explored is their potential impact on the endocrine system, in particular through interaction with the alpha isoform of the estrogen receptor (ERα).

View Article and Find Full Text PDF

Eosinophils are myeloid effector cells whose main homing is the gastrointestinal tract. There, they take part in type I and type II immune responses. They also contribute to other non-immunological homeostatic functions like mucus production, tissue regeneration, and angiogenesis.

View Article and Find Full Text PDF

Platelet aggregation is a complicated process mediated by different signaling pathways. As the process is highly complex and apparently redundant, the relationships between these pathways are not yet fully known. The aim of this project was to study the interconnections among seven different aggregation pathways in a group of 53 generally healthy volunteers aged 20 to 66 years.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the effectiveness of four novel anticoagulants—dabigatran, argatroban, rivaroxaban, and apixaban—by comparing their coagulation responses in blood samples from 50 healthy donors.
  • - Results showed rivaroxaban was most effective in prolonging prothrombin time (PT/INR), while argatroban was best for activated partial thromboplastin time (aPTT).
  • - The study found that higher body mass index (BMI) was linked to a reduced effect of the anticoagulants, and higher cholesterol and triglyceride levels affected aPTT, indicating the need for individualized treatment based on these factors.
View Article and Find Full Text PDF